| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b111d3922c9fd45486c99a8277aec22 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474c16906fb6b781bd2413ea945444d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17633b948c9205a3ab5ea774cbce47b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c10781986bd66b441d1eb6d1efacc78 |
| publicationDate |
2020-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020188110-A1 |
| titleOfInvention |
Peptide inhibitors targeting the cxcl12/hmgb1 interaction and uses thereof |
| abstract |
The present invention provides novel peptides binding to HMGB1 and inhibiting the interaction of HMGB1 and CXCL12. The present invention also provides proteins, virus-like particles, nanoparticles and compositions comprising such peptides and nucleic acids encoding such peptides. In addition, methods for using the peptides are provided. In particular, the peptides are useful in the treatment of inflammation and immune-related diseases. |
| priorityDate |
2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |